Hanall Biopharma, 3Q Operating Profit 2 Billion KRW... 109% Increase
[Asia Economy Reporter Ji Yeon-jin] HanAll Biopharma announced on the 27th that its sales in the third quarter of this year reached 25.4 billion KRW, an increase of 15.2% compared to the same period last year.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- [New York Stock Exchange] Major Indexes Close Up Over 1% as Treasury Yields and Oil Prices Fall
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Operating profit during this period was 2 billion KRW, up 109.7%, while net profit decreased by 48.3% to 1.8 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
